Physician profile
Bethann Mallon
NPI 1598389496
$65,487.31
in general payments reported to CMS, 2019-2025
8 companies · $8,554 in 2025
The $8,554 reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $720 · 2022: $18K · 2023: $31K · 2024: $8,083 · 2025: $8,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Food and Beverage: $3,366 · Travel and Lodging: $2,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $41,690.00 |
| Food and Beverage | $3,365.74 |
| Travel and Lodging | $2,109.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $46,362.80 | 2023-2025 | |
| Allergan, INC. | $18,210.52 | 2021-2022 | |
| Galderma Laboratories, L.P. | $557.69 | 2021-2025 | Dysport |
| Merz North America, INC. | $222.44 | 2023-2025 | Xeomin |
| Solta Medical, A Division of Bausch Health US, LLC | $57.55 | 2022-2024 | Clear+Brilliant |
| Revance Therapeutics, INC. | $46.52 | 2025 | Daxxify |
| Janssen Biotech, INC. | $16.97 | 2021 | |
| Strata Skin Sciences, INC. | $12.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethann Mallon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.